Market Place
Sourcing Support
UCB races to regulators after $2B rare disease bet delivers data
05 Feb 2022 //
FIERCEBIOTECH
Biotech funder Lightstone raises another $375M for life sciences investing
14 Sep 2021 //
BIOPHARMADIVE
Another OTC product sale for Sanofi, this one to Hypera Pharma
14 Jul 2021 //
FIERCEPHARMA
UCB Completes the Acquisition of Ra Pharmaceuticals
02 Apr 2020 //
BIOSPACE
Ra Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG
18 Feb 2020 //
BUSINESSWIRE
Ra Pharma Announces Clearance of IND Application for the HEALEY ALS Trial
22 Jan 2020 //
BUSINESSWIRE
UCB tries to win some respect in the crowded psoriasis market
18 Oct 2019 //
ENDPTS
UCB Agrees to Acquire Ra Pharmaceuticals: To Improve Treatment Options
10 Oct 2019 //
BUSINESSWIRE
Ra Pharma Announces Pricing of PO of Common Stock at $32.50 per share
23 Jul 2019 //
BIOSPACE
Ra Pharma Announces Positive gMG Ph 2 & Open-Label, Long-Term Extension Data
07 May 2019 //
BUSINESSWIRE
Ra Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions
09 Apr 2019 //
BUSINESSWIRE
Ra Pharma Announces Acceptance of gMG Phase 2 and Open-Label
02 Apr 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.